Jonathan Solomon, CEO, stated that the third quarter of 2025 was an important period for BiomX, highlighting that "we began the quarter strongly with first patient dosing in our Phase IIb trial, a ...
Jonathan Eitan Solomon does not have any significant net worth to report based on the numbers we have. This is based on reported shares in BiomX Inc..
Good morning, and welcome to the BiomX Second Quarter 2025 Financial Results and Business and Program Update Conference Call. [Operator Instructions] As a reminder, this conference call is being ...
BiomX Inc. beats earnings expectations. Reported EPS is $0, expectations were $-0.32. Operator: Good morning, and welcome to BiomX Third Quarter 2025 Financial Results and Program Update Conference ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results